• Molecular NameProcaterol
  • SynonymNA
  • Weight290.363
  • Drugbank_IDDB01366
  • ACS_NO59828-07-8
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)1.0
  • pkaN/A
  • LogD (pH=7, predicted)-1.53
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.55
  • LogSw (predicted, AB/LogsW2.0)15.32
  • Sw (mg/ml) (predicted, ACD/Labs)2.64
  • No.of HBond Donors4
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds5
  • TPSA81.59
  • StatusFDA approved
  • AdministrationOral, inhalation
  • PharmacologyA short-acting β2-adrenergic receptor agonist used for the treatment of asthma.
  • Absorption_valueN/A
  • Absorption (description)Because of the small therapeutic dose, systemic levels of salmeterol are low or undetectable after inhalation of recommended doses.
  • Caco_2N/A
  • Bioavailability40.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include angina (chest pain), dizziness, dry mouth, fatigue, flu-like symptoms, headache, heart irregularities, high or low blood pressure, high blood sugar, insomnia, muscle cramps, nausea, nervousness, rapid heartbeat, seizures, and tremor.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A